Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ)

CNY 3.83

(-1.03%)

Revenue Summary of Hubei Biocause Pharmaceutical Co., Ltd.

  • Hubei Biocause Pharmaceutical Co., Ltd.'s latest annual revenue in 2023 was 49.72 Billion CNY , up 0.22% from previous year.
  • Hubei Biocause Pharmaceutical Co., Ltd.'s latest quarterly revenue in 2024 Q3 was 4.53 Billion CNY , down -60.78% from previous quarter.
  • Hubei Biocause Pharmaceutical Co., Ltd. reported a annual revenue of 49.61 Billion CNY in annual revenue 2022, up 0.07% from previous year.
  • Hubei Biocause Pharmaceutical Co., Ltd. reported a annual revenue of 49.58 Billion CNY in annual revenue 2021, up 13.79% from previous year.
  • Hubei Biocause Pharmaceutical Co., Ltd. reported a quarterly revenue of 17.37 Billion CNY for 2024 Q1, down -63.98% from previous quarter.
  • Hubei Biocause Pharmaceutical Co., Ltd. reported a quarterly revenue of 11.57 Billion CNY for 2024 Q2, down -33.41% from previous quarter.

Annual Revenue Chart of Hubei Biocause Pharmaceutical Co., Ltd. (2023 - 1995)

Historical Annual Revenue of Hubei Biocause Pharmaceutical Co., Ltd. (2023 - 1995)

Year Revenue Revenue Growth
2023 49.72 Billion CNY 0.22%
2022 49.61 Billion CNY 0.07%
2021 49.58 Billion CNY 13.79%
2020 43.57 Billion CNY -13.18%
2019 50.19 Billion CNY 62.17%
2018 30.95 Billion CNY -42.05%
2017 53.4 Billion CNY 214.23%
2016 16.99 Billion CNY 3040.88%
2015 541.1 Million CNY -32.9%
2014 806.44 Million CNY -16.69%
2013 967.95 Million CNY 24.14%
2012 779.73 Million CNY -31.23%
2011 1.13 Billion CNY -10.1%
2010 1.26 Billion CNY 30.74%
2009 964.6 Million CNY 6.08%
2008 909.28 Million CNY 8.8%
2007 835.75 Million CNY 49.04%
2006 560.75 Million CNY 8.1%
2005 518.72 Million CNY 12.02%
2004 463.04 Million CNY 9.55%
2003 422.67 Million CNY 21.25%
2002 348.61 Million CNY -2.08%
2001 356.01 Million CNY 10.58%
2000 321.96 Million CNY 25.83%
1999 255.86 Million CNY 33.04%
1998 192.31 Million CNY -19.04%
1997 237.53 Million CNY 65.27%
1996 143.72 Million CNY 72.61%
1995 83.26 Million CNY 0.0%

Peer Revenue Comparison of Hubei Biocause Pharmaceutical Co., Ltd.

Name Revenue Revenue Difference
COFCO Capital Holdings Co., Ltd. 24.37 Billion CNY -103.995%